Search

everythinglearnresearchcommunity

for

Search:↓

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Every elderly patient had at least one skin condition, often linked to other diseases, highlighting the need for integrated skin and general healthcare in the elderly.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Minoxidil can cause deadly skin reaction; monitor patients closely.

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Most hospitalized children with skin issues were boys, with allergic skin diseases like atopic dermatitis being most common, and treatments were usually topical.

Effective symptom management in IBD improves quality of life and prevents complications.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Electrospun scaffolds can improve healing in diabetic wounds.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

A woman with Cushing's syndrome improved after surgery to remove a tumor causing the condition.

Finasteride use varies among Denmark, Finland, Norway, and Sweden, with higher usage in Finland and Sweden.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.